Alkem Laboratories Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as per regulatory requirements. This document details the company's equity structure.
Alkem Laboratories notified the exchange that it dispatched web-links for the FY 2025-26 Annual Report to unregistered shareholders. This filing fulfills Regulation 36(1)(b) compliance requirements.
Alkem Laboratories submitted its Annual Secretarial Compliance Report for the financial year 2025-26. The report confirms overall regulatory adherence with no major non-compliance observations.